O'Shaughnessy J - Search Results

1

Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer.

McIntyre K, O'Shaughnessy J, Schwartzberg L, Glück S, Berrak E, Song JX, Cox D, Vahdat LT. McIntyre K, et al. Breast Cancer Res Treat. 2014 Jul;146(2):321-8. doi: 10.1007/s10549-014-2923-9. Epub 2014 Apr 4. Breast Cancer Res Treat. 2014. PMID: 24699910 Free PMC article. Clinical Trial.

2

Phase II trial of gemcitabine plus trastuzumab in metastatic breast cancer patients previously treated with chemotherapy: preliminary results.

O'Shaughnessy J, Vukelja SJ, Marsland T, Kimmel G, Ratnam S, Pippen J. O'Shaughnessy J, et al. Clin Breast Cancer. 2002 May;3 Suppl 1:17-20. doi: 10.3816/cbc.2002.s.004. Clin Breast Cancer. 2002. PMID: 12057040 Clinical Trial.

3

Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results.

O'Shaughnessy J, Miles D, Vukelja S, Moiseyenko V, Ayoub JP, Cervantes G, Fumoleau P, Jones S, Lui WY, Mauriac L, Twelves C, Van Hazel G, Verma S, Leonard R. O'Shaughnessy J, et al. J Clin Oncol. 2002 Jun 15;20(12):2812-23. doi: 10.1200/JCO.2002.09.002. J Clin Oncol. 2002. PMID: 12065558 Clinical Trial.

4

Capecitabine and docetaxel in advanced breast cancer: analyses of a phase III comparative trial.

O'Shaughnessy J. O'Shaughnessy J. Oncology (Williston Park). 2002 Oct;16(10 Suppl 12):17-22. Oncology (Williston Park). 2002. PMID: 12435175 Review.

5

Treatment for anthracycline-pretreated metastatic breast cancer.

O'Shaughnessy J, Twelves C, Aapro M. O'Shaughnessy J, et al. Oncologist. 2002;7 Suppl 6:4-12. doi: 10.1634/theoncologist.7-suppl_6-4. Oncologist. 2002. PMID: 12454314 Free article. Review.

6

Gemcitabine and trastuzumab in metastatic breast cancer.

O'shaughnessy J. O'shaughnessy J. Semin Oncol. 2003 Apr;30(2 Suppl 3):22-6. doi: 10.1053/sonc.2003.37272. Semin Oncol. 2003. PMID: 12722022 Clinical Trial.

7

A pilot study of dose intense doxorubicin and cyclophosphamide followed by infusional paclitaxel in high-risk primary breast cancer.

Zujewski JA, Eng-Wong J, O'Shaughnessy J, Venzon D, Chow C, Danforth D, Kohler DR, Cusack G, Riseberg D, Cowan KH. Zujewski JA, et al. Breast Cancer Res Treat. 2003 Sep;81(1):41-51. doi: 10.1023/A:1025421416674. Breast Cancer Res Treat. 2003. PMID: 14531496 Clinical Trial.

8

Gemcitabine combination chemotherapy in metastatic breast cancer: phase II experience.

O'Shaughnessy J. O'Shaughnessy J. Oncology (Williston Park). 2003 Dec;17(12 Suppl 14):15-21. Oncology (Williston Park). 2003. PMID: 14768400 Free article. Review.

9

Extending survival with chemotherapy in metastatic breast cancer.

O'Shaughnessy J. O'Shaughnessy J. Oncologist. 2005;10 Suppl 3:20-9. doi: 10.1634/theoncologist.10-90003-20. Oncologist. 2005. PMID: 16368868 Free article. Review.

10

A decade of letrozole: FACE.

O'Shaughnessy J. O'Shaughnessy J. Breast Cancer Res Treat. 2007;105 Suppl 1(Suppl 1):67-74. doi: 10.1007/s10549-007-9702-9. Epub 2007 Oct 3. Breast Cancer Res Treat. 2007. PMID: 17912637 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

439 results

Search Page

Filters